# ARAZLO
> **NDA211882** · New Drug Application · Sponsor: BAUSCH · Approved 2019-12-18
## Drug
- **FDA Application Number:** NDA211882
- **Application type:** New Drug Application
- **Brand name:** ARAZLO
- **Generic name:** TAZAROTENE
- **Active ingredients:** TAZAROTENE
- **Dosage form:** LOTION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH
- **Manufacturer:** Bausch Health US, LLC
- **First approval:** 2019-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211882)
---
*MORVS · CC0 1.0*